Historial de carrera de Lynn Connolly
Antiguos cargos conocidos de Lynn Connolly.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INVIVYD, INC. | Director Técnico/Científico/I+D | 01/07/2020 | 25/03/2022 |
| VIR BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01/03/2018 | 01/07/2020 |
| ACHAOGEN | Director Técnico/Científico/I+D | 01/01/2016 | 01/01/2017 |
Formación de Lynn Connolly.
| University of California, Berkeley | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| INVIVYD, INC. | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Lynn Connolly
- Experiencia
